Results 71 to 80 of about 146,743 (148)

SGLT-2 Inhibitors are Associated With a Lower Risk of Multiple Myeloma. [PDF]

open access: yesEur J Haematol
Liu E   +6 more
europepmc   +1 more source

Exploratory Identification of Potential Serum Biomarkers Associated with Relapse in Multiple Myeloma. [PDF]

open access: yesDiseases
Chantkran W   +6 more
europepmc   +1 more source

A Rare Case of Oligosecretory Multiple Myeloma With Intracranial Plasmacytoma. [PDF]

open access: yesCureus
Kabore SOJ   +4 more
europepmc   +1 more source

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

open access: yesHaematologica, 2014
Neha Korde   +22 more
doaj   +1 more source

PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma. [PDF]

open access: yesBlood
Schavgoulidze A   +18 more
europepmc   +1 more source

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide

open access: yesBlood Cancer Journal
Diana Cirstea   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy